Sign in Create account Request Demo

States / U.S. Congress / HR 9635

HR 9635 In Committee

Getting Innovations to Patients During Shutdowns Act

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Overview Bill text 1 History 2 Sponsors
Introduced in House Jul 9, 2026 · 905 words Open full page ↗

I

119TH CONGRESS

2D SESSION

H. R. 9635

To amend the Federal Food, Drug, and Cosmetic Act to establish special

rules to provide for continued review of human drug and device submis-

sions during a lapse of appropriations, and for other purposes.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in